Who
Mark Kaye
EVP & CFO
Company insider
Files Form 4 as: EVP & CFO, Elevance Health; Director, Conmed; EVP & Chief Financial Officer, Moody's.
In numbers
- Trades disclosed
- 121
- Buys
- 0
- Sells
- 14
- Bought
- $0
- Sold
- $14.4M
- Companies
- 3
- Companies where not an officer
- 1
- First trade
- 1 Oct 2018
- Last trade
- 2 Oct 2026
- Last filed
- 6 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Oct 2026filed 6 Oct 2026 | ELV Elevance HealthManaged Care & Insurers | SEC FORM 4 Code F | $1.6M4,161 at $386.43 | filing |
| 2 Oct 2026filed 6 Oct 2026 | ELV Elevance HealthManaged Care & Insurers | SEC FORM 4 Code A | —2,627 at $0.00 | filing |
| 2 Jun 2026filed 3 Jun 2026 | CNMD ConmedMedical Devices | SEC FORM 4 Code M | —668 at $0.00 | filing |
| 2 Jun 2026filed 3 Jun 2026 | CNMD Conmedoption or derivative · Medical Devices | SEC FORM 4 Code M | —668 at $0.00 | filing |
| 2 Jun 2026filed 3 Jun 2026 | CNMD Conmedoption or derivative · Medical Devices | SEC FORM 4 Code M | —668 at $0.00 | filing |
| 2 Jun 2026filed 3 Jun 2026 | CNMD ConmedMedical Devices | SEC FORM 4 Code M | —668 at $0.00 | filing |
| 1 Jun 2026filed 3 Jun 2026 | CNMD Conmedoption or derivative · Medical Devices | SEC FORM 4 Code A | —5,772 at $0.00 | filing |
| 1 Jun 2026filed 3 Jun 2026 | CNMD Conmedoption or derivative · Medical Devices | SEC FORM 4 Code A | —5,772 at $0.00 | filing |
| 3 Mar 2026filed 4 Mar 2026 | ELV Elevance HealthManaged Care & Insurers | SEC FORM 4 Code F | $100K353 at $284.03 | filing |
| 3 Mar 2026filed 4 Mar 2026 | ELV Elevance HealthManaged Care & Insurers | SEC FORM 4 Code F | $100K353 at $284.03 | filing |
| 2 Mar 2026filed 4 Mar 2026 | ELV Elevance HealthManaged Care & Insurers | SEC FORM 4 Code F | $80K271 at $294.07 | filing |
| 2 Mar 2026filed 4 Mar 2026 | ELV Elevance HealthManaged Care & Insurers | SEC FORM 4 Code A | —6,377 at $0.00 | filing |
| 2 Mar 2026filed 4 Mar 2026 | ELV Elevance HealthManaged Care & Insurers | SEC FORM 4 Code A | —10,202 at $0.00 | filing |
| 2 Mar 2026filed 4 Mar 2026 | ELV Elevance Healthoption or derivative · Managed Care & Insurers | SEC FORM 4 Code A | —25,188 at $0.00 | filing |
| 2 Mar 2026filed 4 Mar 2026 | ELV Elevance Healthoption or derivative · Managed Care & Insurers | SEC FORM 4 Code A | —25,188 at $0.00 | filing |
| 2 Mar 2026filed 4 Mar 2026 | ELV Elevance HealthManaged Care & Insurers | SEC FORM 4 Code F | $80K271 at $294.07 | filing |
| 2 Mar 2026filed 4 Mar 2026 | ELV Elevance HealthManaged Care & Insurers | SEC FORM 4 Code A | —6,377 at $0.00 | filing |
| 2 Mar 2026filed 4 Mar 2026 | ELV Elevance HealthManaged Care & Insurers | SEC FORM 4 Code A | —10,202 at $0.00 | filing |
| 24 Feb 2026filed 26 Feb 2026 | CNMD ConmedMedical Devices | SEC FORM 4 Code M | —152 at $0.00 | filing |
| 24 Feb 2026filed 26 Feb 2026 | CNMD Conmedoption or derivative · Medical Devices | SEC FORM 4 Code M | —152 at $0.00 | filing |
News
Elevance Health reaches $425.27, completing a full-year round tripELV · 247wallst.com · 14 Oct 2026Elevance Health (NYSE:ELV) Given New $460.00 Price Target at GuggenheimELV · themarketsdaily.com · 13 Oct 2026Head-To-Head Analysis: Moody's (NYSE:MCO) versus Equus Total Return (NYSE:EQS)MCO · tickerreport.com · 8 Oct 2026
0 headlines in the last 90 days name Mark Kaye; 3 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.